Skip to main content

Table 4 Multiple regression analysis of total inpatient costs

From: Medical costs and hospital utilization for hemophilia A and B urban inpatients in China: a national cross-sectional study

Parameters

Coef.

P>z

95% Wald confidence interval

Lower

Upper

Disease type

(Reference: Hemophilia B)

Hemophilia A

-0.417

0.019

-0.764

-0.070

Age

-0.001

0.764

-0.008

0.006

Number of hospitalizations

0.092

0.000

0.067

0.117

Length of stay

0.004

0.005

0.001

0.007

Region

(Reference: Western)

Eastern

0.768

0.000

0.416

1.120

Central

0.560

0.003

0.191

0.929

City level

(Reference: Class I)

Class III

0.354

0.018

0.061

0.646

Class II

-0.065

0.749

-0.463

0.333

Insurance type

(Reference: URBMI)

UEBMI

0.390

0.011

0.088

0.692

Hospital type

(Reference: Primary)

Tertiary

0.651

0.009

0.166

1.136

Secondary

0.280

0.295

-0.244

0.805

Year

(Reference: 2010)

2011

0.716

0.010

0.171

1.262

2012

0.603

0.026

0.073

1.133

2013

0.755

0.014

0.155

1.355

2014

-0.061

0.855

-0.722

0.599

2015

0.249

0.425

-0.362

0.860

2016

0.300

0.345

-0.322

0.923

Intercept

8.224

0.000

7.508

8.941

  1. Parameter estimates from logged costs, UEBMI: Urban Employee Basic Medical Insurance scheme, URBMI: Urban Resident Basic Medical Insurance scheme